These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2814919)

  • 21. [Hazardous complications after injection of patent blue-violet as a complication lymphography].
    Platzbecker H; Köhler K; Lucas D
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1224-5. PubMed ID: 5504416
    [No Abstract]   [Full Text] [Related]  

  • 22. [False signs of hypoxemia when using the dye Patent Blue V].
    Freudendal-Pedersen A; Partoft S; Larsen VH; Engbaek J; Krag C
    Ugeskr Laeger; 1996 Jan; 158(3):284-5. PubMed ID: 8607209
    [No Abstract]   [Full Text] [Related]  

  • 23. Lymphangiography without blue dyes., Case report of an allergic reaction and technique.
    Ryvicker MJ; Cohen HR; Deutsch AM; Schatz SL
    R I Med J (1976); 1980 Dec; 63(12):494-5. PubMed ID: 6934588
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anaphylactic reaction to patent blue in sentinel node biopsy].
    Galatius H; Holtveg HM; Følsgård SL
    Ugeskr Laeger; 2003 Aug; 165(34):3242-3. PubMed ID: 12970997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate reactions to patent blue dye.
    Kalimo K; Saarni H
    Contact Dermatitis; 1981 May; 7(3):171-2. PubMed ID: 7273743
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasms.
    Amr D; Broderick-Villa G; Haigh PI; Guenther JM; DiFronzo LA
    Am Surg; 2005 Sep; 71(9):720-4. PubMed ID: 16468505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
    Thevarajah S; Huston TL; Simmons RM
    Am J Surg; 2005 Feb; 189(2):236-9. PubMed ID: 15720998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patent blue V encapsulation in liposomes: potential applicability to endolympatic therapy and preoperative chromolymphography.
    Hirnle P; Harzmann R; Wright JK
    Lymphology; 1988 Sep; 21(3):187-9. PubMed ID: 3199875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blue angioedema of eyelip after patent blue injection for lymphatic mapping procedure.
    Weng PW; Hsu HM; Chen TW; Hsieh CB; Chang TM; Chen VT; Yu JC
    Eur J Cancer Care (Engl); 2007 Jul; 16(4):390-1. PubMed ID: 17587366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of isosulfan blue in breast surgery interferes with pulse oximetry.
    Wisely NA; Zeiton Z
    Anaesthesia; 2005 Jun; 60(6):625-6. PubMed ID: 15918843
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immediate hypersensitivity after injection of patent blue violet].
    Van Vaerenbergh PM
    J Belge Radiol; 1967; 50(5):411-2. PubMed ID: 5594569
    [No Abstract]   [Full Text] [Related]  

  • 32. [Patent blue-induced false-methemoglobinemia].
    Hayakawa M; Morimoto Y; Kemmotsu O
    Masui; 2000 Jul; 49(7):774-6. PubMed ID: 10933033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of radioisotope combined with isosulfan Blue dye is not superior to radioisotope alone for the identification of sentinel lymph nodes in patients with breast cancer.
    Bines S; Kopkash K; Ali A; Fogg L; Wool N
    Surgery; 2008 Oct; 144(4):606-9; discussion 609-10. PubMed ID: 18847645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis.
    Raut CP; Daley MD; Hunt KK; Akins J; Ross MI; Singletary SE; Marshall GD; Meric-Bernstam F; Babiera G; Feig BW; Ames FC; Kuerer HM
    J Clin Oncol; 2004 Feb; 22(3):567-8. PubMed ID: 14752082
    [No Abstract]   [Full Text] [Related]  

  • 35. Images in clinical medicine. Blue hives.
    O'Sullivan MJ; Morrow M
    N Engl J Med; 2008 Feb; 358(6):e6. PubMed ID: 18256388
    [No Abstract]   [Full Text] [Related]  

  • 36. [The lens of the eye and its relation to the lymphatic system].
    Fabian G
    Z Lymphol; 1986 Dec; 10(2):39-43. PubMed ID: 3825237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of isosulfan blue for identification of lymphatic vessels: experimental and clinical evaluation.
    Hirsch JI; Tisnado J; Cho SR; Beachley MC
    AJR Am J Roentgenol; 1982 Dec; 139(6):1061-4. PubMed ID: 6983249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative identification of chylous fistulas using iso-sulphan blue dye.
    Rubis PJ; Tisnado J; Hirsch JI; Capehart J
    AJR Am J Roentgenol; 1982 Jul; 139(1):186-7. PubMed ID: 6979857
    [No Abstract]   [Full Text] [Related]  

  • 39. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%.
    Longnecker SM; Guzzardo MM; Van Voris LP
    Clin Pharm; 1985; 4(2):219-21. PubMed ID: 3987223
    [No Abstract]   [Full Text] [Related]  

  • 40. Carcinogenic risk of basic fuchsin.
    Rowland M
    Br Dent J; 1983 Sep; 155(5):145. PubMed ID: 6587856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.